Outcomes after complete dissolution of everolimus-eluting bioresorbable scaffolds implanted during routine practice.
Sign Up to like & getrecommendations! Published in 2020 at "Revista espanola de cardiologia"
DOI: 10.1016/j.rec.2020.07.005
Abstract: INTRODUCTION AND OBJECTIVES Long-term outcomes of unselected patients treated with bioresorbable vascular scaffold (BVS) implantation are lacking, especially for the period after complete dissolution of the BVS. This study sought to evaluate 5-year outcomes in… read more here.
Keywords: complete dissolution; routine practice; practice; everolimus eluting ... See more keywords
Bioresorbable vascular scaffolds: implication of very late scaffold thrombosis.
Sign Up to like & getrecommendations! Published in 2017 at "Coronary Artery Disease"
DOI: 10.1097/mca.0000000000000518
Abstract: Background Everolimus-eluting bioresorbable vascular scaffold (BVS) (Absorb BVS; Abbott Vascular, Santa Clara, California, USA) technology emerged with the promise that late stent-related coronary events could be prevented and coronary artery vasomotion could be restored, returning… read more here.
Keywords: cocr ees; scaffold thrombosis; bioresorbable vascular; thrombosis ... See more keywords